A biomarker may help identify which colorectal cancer patients could benefit from immunotherapy
A team led by the Hospital del Mar Research Institute and IRB Barcelona has identified a biomarker linked to prognosis and likely response to immunotherapy in colon and rectal cancer.
A new tool helps identify what makes each type of pancreatic cell unique
The Endocrine Regulatory Genomics group at MELIS-UPF has developed SPICEY, a tool that helps identify which genes and which DNA regulatory regions are specific to each cell type. Applied to pancreatic islets, it may help us better understand the pancreas in health and diabetes.
Work begins on PRBB Ciutadella, the future biomedical hub at the former Mercat del Peix site
The institutional event held today marks a new step in a strategic project for the PRBB and for the Ciutadella of Knowledge, which aims to strengthen Barcelona as a European hub for biomedical research.
The PRBB will host the 7th NF-kB International Congress
Barcelona will host, from 7 to 9 October 2026, the 7th NF-kB International Congress, organised by the Hospital del Mar Research Institute (HMRIB) and devoted to one of the key molecular pathways in inflammation, immunity, development and cancer.
